AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

The Phase I/IIa trial is a multinational, multicenter study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe ...

Forbes contributors publish independent expert analyses and insights. Tony Bradley covers the intersection of tech and entertainment. In recent years, the security industry has treated visibility as ...

President Donald Trump's triumphant assessment of his achievements in a year-end White House address to the nation offered nary a nod to the troubles now rising around him. "Over the past 11 months, ...

I’m with you. It’s a phase; it’ll pass. What’s the hurry? Indeed, “impatient” is an interesting word to describe how your husband is feeling about your child’s eating. I am pretty sure he knows that ...

NFL fans not happy with schedule problem The two biggest games of the week airing the same time on the same network is not ideal. The Cowboys and Vikings, meanwhile, will kick off at 8:20 p.m. E.T.

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Nomura Holdings Inc.’s chief executive officer vowed to build on the company’s earnings revival by strengthening businesses across the board, ranging from wealth to asset management and dealmaking. “I ...

BEIJING, Nov. 27, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced the initiation of GRADUAL-3, its third large-scale phase 3 clinical study of the ...

There is plenty of blame to go around in Los Angeles after the Clippers' 3-7 start. Ty Lue's decisions, Kawhi Leonard and Bradley Beal's absences, and the underperformance of several veterans have all ...